This session provides an analysis and discussion of the role evidence-based practice can play in improving the treatment and outcome for CKD patients with mineral bone disorders. Discussion focuses on the success of current evidence-based practices that support the early and aggressive treatment of hyperphosphatemia, along with the role that hypercalcemia can play in treatment, and a comparison of the pharmacotherapeutic agents available to help treat these disorders is explored.
You must be logged in and own this session in order to post comments.
